Hence, we used GO and KEGG analyses, GSEA, PPI network construction, immune infiltration and immune checkpoint correlations, and drug sensitivity analysis to explore the underlying molecular pathological mechanisms of SLC25A21 in AML. The gene discussed is SLC25A21; the disease is acute myeloid leukemia.